Skip to content

Released Mar 31, 2014, during market hours

10-K filed Mar 31, 2014, 90 days after period end · 0001144204-14-019291

Q4 2013 · 10-K

derived · Computed from the longer spans the company filed.

Revenue—
Net Income-$4.39MderivedN/M vs Q4 2012N/M vs Q3 2013
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$4,412,506—
Operating Cash Flowderived-$4,113,068—
Free Cash Flowderived-$4,113,068N/M

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-K.

Same quarter

MetricQ4 2013derived from reported figuresQ4 2012derived from reported figuresQ4 2011
Net Income-$4.39M$5.02M-$5.16K

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR